The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAVI Global Trust Regulatory News (AGT)

Share Price Information for AVI Global Trust (AGT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 242.00
Bid: 241.00
Ask: 241.50
Change: 3.00 (1.26%)
Spread: 0.50 (0.207%)
Open: 239.00
High: 242.00
Low: 238.00
Prev. Close: 239.00
AGT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monthly Factsheet

7 Jun 2023 16:39

RNS Number : 0011C
AVI Global Trust PLC
07 June 2023
 

 

AVI GLOBAL TRUST PLC

 

Monthly Update

 

AVI Global Trust plc (the "Company") presents its Update, reporting performance figures for the month ended 31 May 2023.

 

This Monthly Newsletter is available on the Company's website at:

https://www.assetvalueinvestors.com/content/uploads/2023/06/AGT-MAY-2023.pdf

 

Performance Total Return

 

This investment management report relates to performance figures to 31 May 2023.

 

Total Return (£)

Month

Calendar Yr

to date

1Y

3Y

5Y

10Y

AGT NAV

1.0%

1.5%

0.2%

54.1%

40.5%

119.4%

MSCI ACWI Ex US

-2.3%

1.7%

0.3%

23.0%

19.8%

78.1%

MSCI ACWI

0.3%

4.5%

2.6%

33.0%

49.0%

159.8%

 

 

Manager's Comment

 

AVI Global Trust (AGT)'s NAV increased by +1.0% in May.

 

Schibsted (+17%), FEMSA (+5%) and Apollo (+6%) were the largest positive contributors. Aker (-7%), Digital Garage (- 20%) and Christian Dior (-7%) were the most meaningful detractors.

 

Spectrum Brands Holdings

 

During the month we exited Spectrum Brands Holdings ("Spectrum Brands"), the US conglomerate.

 

As detailed in our January newsletter, we built a position in the company after the shares nosedived as the Department of Justice ("DOJ") attempted to block the sale of its locks business to Assa Abloy. We believed the market was mispricing the probability of the deal passing and awarding an unduly low value to Spectrum Brands' other businesses, even in a scenario where the deal was blocked.

 

In early May the DOJ relented and settled with Spectrum Brands, approving the deal with completion expected by June 30th. This led to a jump in the shares, and we sold out swiftly as the shares started to better reflect fair value, trading at a 20% discount to our estimated NAV.

 

Whilst there is still potential for significant capital returns and a long-term re-rating story, we grew more cautious on the earnings outlook of the remaining businesses, particularly for the Homes & Garden division. Moreover, we are cognisant of the extent to which the company still warrants a considerable conglomerate discount until the Household Personal Care (HPC) business is divested - the timeline for which is unclear.

 

Over the short holding period AGT generated a +13% ROI / +54% IRR vs. +4% / +16% for the MSCI ACWI (both in $). Although the ROI on our initial purchases approached 60%, this was dampened down by more material additions at higher levels (generating~10% returns) as the event drew closer and our conviction and assessed probability of a positive outcome increased. Regardless, we believe the investment highlights how special situation events can generate positive absolute returns over relatively short periods in sideways markets. Moreover, we like the flexibility resulting from converting ~5% of our NAV into cash at a time when new ideas are plentiful.

 

FEMSA

At the end of May FEMSA took further steps to unlock value, driving the shares +5% higher over the month.

As readers may remember from February's newsletter, early this year the company concluded its strategic review which will see FEMSA simplify its group structure and re-focus on its core businesses; exiting its stake in Heineken and selling other non-core assets.

 

Kicking the process off, in February FEMSA sold €3.2bn of Heineken/Heineken Holding stock in an accelerated book build and issued a €500m bond exchangeable in Heineken Holding shares.

 

At the end of May the company took further steps, selling $3.7bn of Heineken / Heineken Holding stock. As such, the company has now fully exited Heineken (bar the shares underlying the exchangeable bond). As well as this FEMSA announced the sale of Jetro Restaurant Depot ("JRD") for $1.4bn.

 

FMX shares have now moved over +70% off the lows they hit last July (where we averaged down!). The stub has re-rated considerably from the all-time-low 5.7x EV/ NTM EBITDA to 8.2x currently, and earnings have also grown significantly (EBITDA for the next twelve months +21% today versus then).

 

It is this latter point which is particularly important to us - asset quality and the prospect for NAV growth is key to our style of investing. Q1 results show Oxxo to be in rude health, with the fastest rate of Same Store Sales growth in Mexico in more than 20 years at +19%. Both ticket and traffic contributed to this and there is likely more to come from both, with a continued mix-effect to higher priced items such as spirits and pantry items, where Oxxo started to gain traction during the pandemic, and a continued recovery in traffic. New store openings are now running above >1k on a trailing twelve-month basis once again, and we believe the company can reach c.30k units in Mexico by the end of the decade (from just shy of 22k currently). As well as this we are increasingly encouraged by the company's operations in Brazil, a notoriously difficult market but one where FEMSA and their JV partners are showing a high and consistent level of performance. Success here would significantly extend the growth runway and we expect investor attention to increasingly turn to this as the business scales and disclosure improves.

 

Despite strong performance we believe the shares remain cheaply priced, trading at a 29% discount to our estimated NAV and with the stub at an inordinately wide discount to Walmex (8.2x vs. 12.0x). Pro-forma of the above transactions, we estimate that net debt to EBITDA stands at c.0.4x vs. management's target of 2.0x. This implies the company has "excess" capital equating to c.15% of its market cap. Investors, not entirely without reason, are cautious over how this will be deployed, and we have been encouraging management to use the proceeds for share buybacks.

 

Contributors / Detractors (in GBP)

 

Largest Contributors

1- month contribution

bps

% Weight

Schibsted ASA 'B'

92

7.5

FEMSA

35

5.9

Apollo Global Mgmt.

31

4.4

IAC

27

3.2

Spectrum Brands Holdings

25

0.0

 

Largest Detractors

1- month contribution

bps

% Weight

Aker ASA

-55

5.3

Christian Dior

-42

4.2

Digital Garage

-31

1.7

D'Ieteren

-25

4.2

Brookfield/Short SPY

-24

5.0

 

 

Link Company Matters Limited

Corporate Secretary

 

07 June 2023

 

LEI: 213800QUODCLWWRVI968

 

The content of the Company's web-pages and the content of any website or pages which may be accessed through hyperlinks on the Company's web-pages, other than the content of the Newsletter referred to above, is neither incorporated into nor forms part of the above announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCUPUMWQUPWGAM
Date   Source Headline
3rd May 20242:08 pmRNSNet Asset Value(s)
2nd May 20245:43 pmRNSTransaction in Own Shares
2nd May 20241:55 pmRNSNet Asset Value(s)
1st May 20241:39 pmRNSNet Asset Value(s)
1st May 20247:00 amRNSTotal Voting Rights
30th Apr 202412:30 pmRNSNet Asset Value(s)
29th Apr 20241:34 pmRNSNet Asset Value(s)
26th Apr 202412:06 pmRNSNet Asset Value(s)
25th Apr 20241:57 pmRNSNet Asset Value(s)
24th Apr 202412:34 pmRNSNet Asset Value(s)
23rd Apr 20241:00 pmRNSNet Asset Value(s)
22nd Apr 202412:54 pmRNSNet Asset Value(s)
19th Apr 20245:35 pmRNSTransaction in Own Shares
19th Apr 20243:39 pmRNSNet Asset Value(s)
19th Apr 20247:00 amRNSCompliance with Market Abuse Regulation
18th Apr 20245:40 pmRNSTransaction in Own Shares
18th Apr 202412:18 pmRNSNet Asset Value(s)
17th Apr 202412:24 pmRNSNet Asset Value(s)
16th Apr 202412:31 pmRNSNet Asset Value(s)
15th Apr 202412:44 pmRNSNet Asset Value(s)
12th Apr 20245:30 pmRNSTransaction in Own Shares
12th Apr 20242:09 pmRNSNet Asset Value(s)
11th Apr 20245:49 pmRNSTransaction in Own Shares
11th Apr 202412:59 pmRNSNet Asset Value(s)
10th Apr 20245:44 pmRNSTransaction in Own Shares
10th Apr 20241:01 pmRNSNet Asset Value(s)
9th Apr 20245:40 pmRNSTransaction in Own Shares
9th Apr 20243:48 pmRNSMonthly Factsheet
9th Apr 202412:20 pmRNSNet Asset Value(s)
9th Apr 202411:56 amRNSDirector/PDMR Shareholding
8th Apr 20244:58 pmRNSDirector/PDMR Shareholding
8th Apr 202412:58 pmRNSNet Asset Value(s)
8th Apr 202412:53 pmRNSAppointment of Corporate Broker
8th Apr 202412:39 pmRNSListing Rule 15.6.8
5th Apr 20241:57 pmRNSNet Asset Value(s)
4th Apr 20245:32 pmRNSTransaction in Own Shares
4th Apr 20241:13 pmRNSNet Asset Value(s)
3rd Apr 20245:32 pmRNSTransaction in Own Shares
3rd Apr 20242:28 pmRNSNet Asset Value(s)
3rd Apr 20247:00 amRNSKepler Trust Intelligence: New Research
2nd Apr 20245:30 pmRNSTransaction in Own Shares
2nd Apr 20244:32 pmRNSNet Asset Value(s)
2nd Apr 202412:31 pmRNSTotal Voting Rights
28th Mar 20245:32 pmRNSTransaction in Own Shares
28th Mar 20242:08 pmRNSNet Asset Value(s)
27th Mar 20245:48 pmRNSTransaction in Own Shares
27th Mar 20243:27 pmRNSNet Asset Value(s)
26th Mar 20245:23 pmRNSTransaction in Own Shares
26th Mar 20242:12 pmRNSNet Asset Value(s)
25th Mar 20245:29 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.